Literature DB >> 21691720

Pathologic evaluation of non-neoplastic renal parenchyma in partial nephrectomy specimens.

Michael Garcia-Roig1, Michael A Gorin, Carlos Parra-Herran, Monica Garcia-Buitrago, Bruce R Kava, Merce Jorda, Mark S Soloway, Murugesan Manoharan, Gaetano Ciancio.   

Abstract

PURPOSE: This study aimed to identify non-neoplastic pathologic changes in partial nephrectomy specimens of patients without a known history of medical comorbidities. Routine analysis of this tissue may allow the clinician to identify subclinical renal disease.
METHODS: We retrospectively reviewed our database of patients who underwent open partial nephrectomy for a small renal mass. Non-neoplastic tissue of partial nephrectomy specimens of patients without a known history of chronic kidney disease, diabetes mellitus, hypertension, or coronary artery disease was evaluated for glomerular, interstitial, and vascular pathologic changes.
RESULTS: A rim of non-neoplastic tissue was adequate for pathologic evaluation in 91.8% of specimens. A total of 45 patients were studied with a median age of 52.0 years. Atherosclerosis was the most commonly identified pathologic finding in 9 (20%) patients, followed by mesangial expansion and interstitial fibrosis, each found in 8 (17.8%) patients. Linear regression found interstitial fibrosis to be the only pathologic lesion associated with preoperative serum creatinine (coefficient = 0.697, P = 0.001). Male gender was also associated with a higher preoperative creatinine (coefficient = 0.270, P = 0.034). Postoperative serum creatinine was not associated with any of the examined lesions.
CONCLUSIONS: Current surgical techniques provide adequate non-neoplastic tissue for pathologic evaluation. We observed a striking degree of pathologic disease in patients without a known history of medical comorbidities. Routine inspection of the non-neoplastic parenchyma of partial nephrectomy specimens should be performed as it can alert the clinician to presence subclinical renal disease allowing for medical intervention.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21691720     DOI: 10.1007/s00345-011-0720-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  17 in total

1.  Protocol for the examination of specimens from patients with invasive carcinoma of renal tubular origin.

Authors:  John R Srigley; Mahul B Amin; Brett Delahunt; Steven C Campbell; Anthony Chang; David J Grignon; Peter A Humphrey; Bradley C Leibovich; Rodolfo Montironi; Andrew A Renshaw; Victor E Reuter
Journal:  Arch Pathol Lab Med       Date:  2010-04       Impact factor: 5.534

2.  Prognostic importance of resection margin width after nephron-sparing surgery for renal cell carcinoma.

Authors:  Elias A Castilla; Louis S Liou; Neil A Abrahams; Amr Fergany; Lisa A Rybicki; Jonathan Myles; Andrew C Novick
Journal:  Urology       Date:  2002-12       Impact factor: 2.649

3.  Is a 1-CM margin necessary during nephron-sparing surgery for renal cell carcinoma?

Authors:  N Y Piper; J T Bishoff; C Magee; J M Haffron; R C Flanigan; A Mintiens; H P Van Poppel; I M Thompson; W J Harmon
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

4.  Rising incidence of renal cell cancer in the United States.

Authors:  W H Chow; S S Devesa; J L Warren; J F Fraumeni
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

Review 5.  Progression in chronic kidney disease.

Authors:  Allison A Eddy
Journal:  Adv Chronic Kidney Dis       Date:  2005-10       Impact factor: 3.620

6.  Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure.

Authors:  Vanesa Bijol; Gonzalo P Mendez; Shelley Hurwitz; Helmut G Rennke; Vânia Nosé
Journal:  Am J Surg Pathol       Date:  2006-05       Impact factor: 6.394

Review 7.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Authors:  Giuseppe Remuzzi; Ariela Benigni; Andrea Remuzzi
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

8.  National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization?

Authors:  Brent K Hollenbeck; David A Taub; David C Miller; Rodney L Dunn; John T Wei
Journal:  Urology       Date:  2006-01-25       Impact factor: 2.649

Review 9.  The epidemiology of renal cell carcinoma.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  J Urol       Date:  2006-12       Impact factor: 7.450

10.  Non-neoplastic renal diseases are often unrecognized in adult tumor nephrectomy specimens: a review of 246 cases.

Authors:  Kammi J Henriksen; Shane M Meehan; Anthony Chang
Journal:  Am J Surg Pathol       Date:  2007-11       Impact factor: 6.394

View more
  7 in total

1.  Comprehensive Analysis of Factors Affecting Post-partial Nephrectomy Renal Global Function.

Authors:  Takehiro Sejima; Tetsuya Yumioka; Noriya Yamaguchi; Hideto Iwamoto; Toshihiko Masago; Shuichi Morizane; Masashi Honda; Atsushi Takenaka
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

2.  Significance of the nonneoplastic renal parenchymal findings in robotic partial nephrectomy series.

Authors:  Ercan Malkoç; Matthew J Maurice; Oktay Akça; Önder Kara; Homayoun Zargar; Hiury Andrade; Daniel Ramirez; Peter Caputo; Robert Stein; Demirjian Sevag; Jihad H Kaouk
Journal:  J Nephrol       Date:  2018-02-16       Impact factor: 3.902

3.  Atherosclerosis within the non-neoplastic margin of partial nephrectomy specimens: implications for medical management.

Authors:  Michael A Gorin; Michael Garcia-Roig; Monica Garcia-Buitrago; Carlos Parra-Herran; Merce Jorda; Gaetano Ciancio
Journal:  World J Urol       Date:  2012-11-28       Impact factor: 4.226

Review 4.  Risk of chronic kidney disease after nephrectomy for renal cell carcinoma.

Authors:  Seung-Kwon Choi; Cheryn Song
Journal:  Korean J Urol       Date:  2014-10-10

5.  Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens.

Authors:  Xun Wang; Qiang Liu; Wen Kong; Jiwei Huang; Yonghui Chen; Yiran Huang; Jin Zhang
Journal:  BMC Cancer       Date:  2017-12-28       Impact factor: 4.430

6.  Association of Ancillary Pathology Findings in Non-neoplastic Renal Parenchyma and Renal Outcomes of Robotic-Assisted Partial Nephrectomy.

Authors:  Laura E Geldmaker; Amanda E Kahn; Kevin A Parikh; Ivan E Porter; Daniela A Haehn; Essa M Bajalia; Qihui Zhai; Colleen T Ball; David D Thiel
Journal:  Front Surg       Date:  2021-04-16

7.  More than ancillary records: clinical implications of renal pathology examination in tumor nephrectomy specimens.

Authors:  Johannes Philipp Kläger; Ahmad Al-Taleb; Mladen Pavlovic; Andrea Haitel; Eva Comperat; Harun Fajkovic; Željko Kikić; Renate Kain; Nicolas Kozakowski
Journal:  J Nephrol       Date:  2021-04-22       Impact factor: 3.902

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.